These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 27564657

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM, Cooper AJ, Lwaleed BA.
    Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
    [Abstract] [Full Text] [Related]

  • 27. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN, Meijers JC.
    J Thromb Haemost; 2003 Jul; 1(7):1566-74. PubMed ID: 12871292
    [Abstract] [Full Text] [Related]

  • 28. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME.
    J Biol Chem; 1998 Oct 16; 273(42):27176-81. PubMed ID: 9765237
    [Abstract] [Full Text] [Related]

  • 29. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE.
    Hamostaseologie; 2007 Sep 16; 27(4):278-81. PubMed ID: 17938767
    [Abstract] [Full Text] [Related]

  • 30. Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors.
    Gils A, Ceresa E, Macovei AM, Marx PF, Peeters M, Compernolle G, Declerck PJ.
    J Thromb Haemost; 2005 Dec 16; 3(12):2745-53. PubMed ID: 16359512
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
    Colucci M, Pentimone A, Binetti BM, Cramarossa M, Piro D, Semeraro N.
    Thromb Haemost; 2002 Aug 16; 88(2):282-7. PubMed ID: 12195701
    [Abstract] [Full Text] [Related]

  • 34. Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
    Antovic JP, Schulman S, An SS, Greenfield RS, Blombäck M.
    Scand J Clin Lab Invest; 2004 Aug 16; 64(8):745-51. PubMed ID: 15719893
    [Abstract] [Full Text] [Related]

  • 35. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
    Bajzar L, Nesheim ME, Tracy PB.
    Blood; 1996 Sep 15; 88(6):2093-100. PubMed ID: 8822928
    [Abstract] [Full Text] [Related]

  • 36. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 15; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 37. Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
    Morishima Y, Kamisato C, Honda Y.
    J Thromb Thrombolysis; 2020 Jan 15; 49(1):94-99. PubMed ID: 31396790
    [Abstract] [Full Text] [Related]

  • 38. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
    Wang W, Nagashima M, Schneider M, Morser J, Nesheim M.
    J Biol Chem; 2000 Jul 28; 275(30):22942-7. PubMed ID: 10801821
    [Abstract] [Full Text] [Related]

  • 39. Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.
    Bazzi ZA, Balun J, Cavallo-Medved D, Porter LA, Boffa MB.
    Clin Exp Metastasis; 2017 Feb 28; 34(2):155-169. PubMed ID: 28124276
    [Abstract] [Full Text] [Related]

  • 40. Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.
    Bridge KI, Bollen L, Zhong J, Hesketh M, Macrae FL, Johnson A, Philippou H, Scott DJ, Gils A, Ariёns RAS.
    J Thromb Haemost; 2017 Nov 28; 15(11):2218-2225. PubMed ID: 28834317
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.